[Overview of COVID-19 vaccines licensed in the EU-from technology via clinical trial to registration]Review Published on 2022-12-012023-07-10 Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesu [Category] COVID19(2023년), [키워드] adjuvant immune response nanoparticle Platform technology SARS-CoV2. [DOI] 10.1007/s00103-022-03600-4 PMC 바로가기 [Article Type] Review
Novel Vaccine Adjuvants as Key Tools for Improving Pandemic PreparednessPerspective Published on 2021-10-242022-10-28 Journal: Bioengineering [Category] COVID-19, [키워드] accelerate adjuvant adjuvants Antigen approved cellular immunity COVID-19 pandemic Critical effective Effective vaccines Efficacy event Future global health healthcare highlight Humoral immunity immunology IMPROVE improvement Improving Infectious disease infectious disease outbreak Innate immunity measure mRNA novel pandemic Pandemics pathogen Pathogens Perspective platform Platform technology public health rapid response reducing stability Vaccine Vaccines [DOI] 10.3390/bioengineering8110155 PMC 바로가기 [Article Type] Perspective
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?IABS/CEPI 플랫폼 기술 웨비나: 백신 개발 시간 단축이 가능한가?Article Published on 2021-06-012022-08-31 Journal: Biologicals : journal of the International Associa [Category] MERS, SARS, 변종, 신약개발, [키워드] Alliance backbone Biological Biological Standardization Coalition component COVID-19 COVID-19 vaccine development disease Diseases Emerging infectious diseases faster Genetic Infectious diseases Innovation input joint meeting organized pandemic pathogen Pathogens platform Platform technology protein sequences rapid response reduce Regulatory Regulatory Authorities regulatory authority SARS-CoV-2 the vaccine Vaccine development Vaccine development. variants of SARS-CoV-2 [DOI] 10.1016/j.biologicals.2021.04.005 PMC 바로가기 [Article Type] Article